clinical research

Novotech Boosts US Presence with NCGS Buy

Asia-Pacific contract research organization (CRO) Novotech has acquired NCGS, a US CRO with about 300 employees and a biopharma client base. Financial terms of the transaction were not disclosed. “This is a strategic move to provide US-based expertise and infrastructure for our US clients wanting trials in Asia-Pacific and the US, and for our Asia-Pacific clients wanting US clinical program, said Novotech CEO John Moller.

Court Stops EU Regulator Releasing Drug Company Data

Breaking New Ground